Haotian Lin MD PhD, Director of DAIBD, ZOC, China
更新时间：2019/3/18 14:15:11
Haotian Lin is a PhD supervisor, the winner of Outstanding Youth Science Foundation, the chief scientist of National Key R&D Program of China, the “Youth Pearl River Scholar” of Universities and Colleges of Guangdong Province, and the leader of technology innovation of “special support plan” of Guangdong Province. Prof. Lin also serves as the director of Department of Artificial Intelligence and Big Data of Zhongshan Ophthalmic Center of Sun Yat-Sen University, the deputy director of the Intelligent Medical Committee of the Chinese Artificial Intelligence Society, the young member of the Ophthalmology Academy of Chinese Medical Association, the director of the Translational Medicine of Guangdong Province, and in the editorial board of several international SCI journals. Prof. Lin is active in clinical practice as well as academic activity. He has published more than 60 SCI papers as the first and corresponding authors in the top international journals like "Nature", "Science", "Lancet", "BMJ", and "PLoS Med" in the past five years. Among them, a new cataract therapy successfully applied in clinical was published (Nature 2016), and was named as one of the “eight breakthroughs in life medicine in 2016” by Nature Medicine. He built the first cloud platform of intelligent diagnosis and treatment of cataract in the world (Nat. Biomed. Eng. 2017, cover paper), and is the creator of the world’s first intelligently ophthalmic clinic in Guangzhou, which was selected as one of "the 11 major AI events affecting the global medical community" by IEEE Spectrum and was the only selected one completed by a Chinese team.
会议日期
2019年5月24-26日
网上注册截止日期
2019年5月23日
现场报到日期
2019年5月24日
美迪康会务通